From Lab Bench to Bedside: Overcoming Manufacturing and Scalability Challenges for Personalized Gene Editing Treatments
The Gene Editing Market Share dynamics are heavily influenced by the intensely competitive and litigious intellectual property (IP) landscape, particularly surrounding the foundational nuclease systems. Market share is not simply won through scientific discovery but is fiercely protected and enforced through complex patent portfolios and licensing agreements. The ownership and freedom to...
0 Comments 0 Shares 247 Views 0 Reviews